Search

Read about why Jae Park joined his colleagues at MSK and New York-Presbyterian to publicly show a united stance against hate.

… Thursday, April 1, 2021 MSK hematologic oncologist Jae Park Jae Park Female doctor wearing a mask and surrounded by her colleagues A large group of doctors and nurses congregating Four doctors wearing white coats and masks A large group of doctors and nurses congregating Over the past few weeks, Jae

Charles Sawyers, MD, Director of the Human Oncology and Pathogenesis Program at Memorial Sloan Kettering Cancer Center and a Howard Hughes Medical Institute investigator, has been named a "Dream Team" leader by Stand Up To Cancer and will co-lead a collaborative team that will receive $15 million to study targeted therapies to treat women's cancers.

… Wednesday, May 27, 2009 Charles Sawyers , MD, Director of the Human Oncology and Pathogenesis Program at Memorial Sloan Kettering Cancer Center (MSKCC) and a Howard Hughes Medical Institute investigator, has been named a “Dream Team” leader by Stand Up To Cancer and will co-lead a collaborative team

Despite the recent development of novel hormonal therapies - such as enzalutamide and abiraterone - directed at the androgen receptor in the management of castration-resistant prostate cancer, a proportion of men have disease that progresses on these drugs.

… Monday, June 5, 2017 Despite the recent development of novel hormonal therapies - such as enzalutamide and abiraterone - directed at the androgen receptor in the management of castration-resistant prostate cancer, a proportion of men have disease that progresses on these drugs. In this video Dr. Howard

In a dramatic shift since the publication of margin guidelines for breast cancer surgery, lumpectomy rates have substantially increased and more-aggressive surgical options have been used less often, according to research findings from a new study being presented at the 2017 annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago. The study will also be published in a corresponding issue of JAMA Oncology.

… Monday, June 5, 2017 In a dramatic shift since the publication of margin guidelines for breast cancer surgery, lumpectomy rates have substantially increased and more-aggressive surgical options have been used less often, according to research findings from a new study being presented at the 2017 annual

Investigators at Memorial Sloan Kettering Cancer Center have found new clues about how metastatic cancer can form long after a primary tumor has been removed.

… Monday, December 1, 2008 Summary Investigators at Memorial Sloan Kettering Cancer Center have found new clues about how metastatic cancer can form long after a primary tumor has been removed. Investigators at Memorial Sloan Kettering Cancer Center have found new clues about how metastatic cancer can

Department of Surgery Chair Jeffrey Drebin discusses MSK’s approach to robotic surgery in response to a recent FDA advisory.

… Friday, March 8, 2019 Summary Jeffrey Drebin, Chair of the Department of Surgery, discusses MSK’s approach to robotic surgery and the importance of having a skilled surgeon for cancer operations. On February 28, the US Food and Drug Administration released a statement cautioning about the use of robotic

May 23, 2007 NEW YORK - The Bright Horizons Foundation for Children, Memorial Sloan Kettering Cancer Center (MSKCC), Abyssinian Development Corporation (ADC), and Community Playthings today cut ribbons to officially open Harlem's first Bright Space center for homeless children at Abyssinian House, a Tier II transitional residence serving the families of Harlem.

… Wednesday, May 23, 2007 The Bright Horizons Foundation for Children, Memorial Sloan Kettering Cancer Center (MSKCC), Abyssinian Development Corporation (ADC), and Community Playthings today cut ribbons to officially open Harlem’s first Bright Space center for homeless children at Abyssinian House, a

MSK today announced a $20 million gift from the Ge Li & Ning Zhao Family Foundation to support lung cancer research and the development of new therapies to treat this disease.

… Thursday, May 13, 2021 Memorial Sloan Kettering Cancer Center (MSK) today announced a $20 million gift from the Ge Li & Ning Zhao Family Foundation to support lung cancer research and the development of new therapies to treat this disease. Lung cancer is responsible for 25 percent of all cancer deaths

Memorial Sloan Kettering Cancer Center (MSKCC) is now poised to take greater advantage of a new era in cancer research and education with the opening of a state-of-the-art research center, the establishment of a new graduate school, and the founding of a novel research program in human oncology.

… Monday, September 18, 2006 Memorial Sloan Kettering Cancer Center (MSKCC) is now poised to take greater advantage of a new era in cancer research and education with the opening of a state-of-the-art research center, the establishment of a new graduate school, and the founding of a novel research program

Many people don’t know that gastroesophageal reflux disease (GERD) is a potentially serious condition that — if left untreated — can ultimately lead to esophageal cancer.

… Thursday, June 30, 2022 Summary Gastroesophageal reflux disease (GERD) is a potentially serious condition that, untreated, can lead to esophageal cancer. MSK surgeon Daniela Molena and medical oncologist Ryan Sugarman discuss what you should know about the treatment and prognosis for GERD, a related